REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 67 filers reported holding REPARE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.10 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $777,311 | +13.0% | 64,347 | -1.0% | 0.00% | – |
| Q2 2023 | $687,890 | -9.2% | 65,018 | -15.6% | 0.00% | – |
| Q1 2023 | $757,788 | -20.1% | 77,011 | +19.5% | 0.00% | – |
| Q4 2022 | $947,972 | +58.5% | 64,444 | +30.7% | 0.00% | – |
| Q3 2022 | $598,000 | -14.6% | 49,310 | -1.5% | 0.00% | – |
| Q2 2022 | $700,000 | +17.8% | 50,075 | +20.0% | 0.00% | – |
| Q1 2022 | $594,000 | -9.5% | 41,745 | +34.2% | 0.00% | – |
| Q4 2021 | $656,000 | -37.8% | 31,096 | -22.6% | 0.00% | – |
| Q3 2021 | $1,054,000 | -49.3% | 40,157 | -39.7% | 0.00% | – |
| Q2 2021 | $2,077,000 | +24.4% | 66,618 | +22.5% | 0.00% | – |
| Q1 2021 | $1,669,000 | +172.3% | 54,370 | +204.0% | 0.00% | – |
| Q4 2020 | $613,000 | +60.1% | 17,883 | +44.8% | 0.00% | – |
| Q2 2020 | $383,000 | – | 12,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $28,001,631 | 33.22% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $23,727,089 | 11.64% |
| CHI Advisors LLC | 2,998,734 | $31,726,606 | 9.63% |
| MPM BioImpact LLC | 1,639,849 | $17,349,602 | 3.49% |
| BVF INC/IL | 8,291,988 | $87,729,233 | 2.44% |
| Deep Track Capital, LP | 2,727,606 | $28,858,071 | 1.34% |
| Redmile Group, LLC | 2,428,335 | $25,691,784 | 0.99% |
| HighVista Strategies LLC | 165,173 | $1,747,530 | 0.80% |
| Orbimed Advisors | 3,322,488 | $35,151,923 | 0.64% |
| DIFESA CAPITAL MANAGEMENT, LP | 15,416 | $163,101 | 0.43% |